COVID‐19 is still prevalent in more world regions and poses a severe threat to human
health due to its high pathogenicity. The incidence of COPD patients is gradually increasing …

Abstract Coronavirus disease 2019 (COVID-19) has speedily increased mortality globally.
Although they are risk factors for severe acute respiratory syndrome coronavirus 2 (SARS …

This article aims to explore hub genes related to different clinical types of cases with COVID-
19 and predict the therapeutic drugs related to severe cases. The expression profile of …

Background: The COVID-19 pandemic poses an imminent threat to humanity, especially for
those who have comorbidities. Evidence of COVID-19 and COPD comorbidities is …

ABSTRACT Coronavirus disease (COVID-19) is an extremely contagious and cognitive
disease that could cause immense hypoxemia. The rise in critically ill patients in epidemic …

Background At the end of 2019, the world witnessed the emergence and ravages of a viral
infection induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Also …

Abstract Current coronavirus disease-2019 (COVID-19) pandemic has caused massive loss
of lives. Clinical trials of vaccines and drugs are currently being conducted around the world; …

Background Since the outbreak of coronavirus disease 2019 (COVID-19) in China,
numerous research institutions have invested in the development of anti-COVID-19 vaccines …

The SARS-CoV-2 virus causes Coronavirus disease, an infectious disease. The majority of
people who are infected with this virus will have mild to moderate respiratory symptoms …

Background The coronavirus disease 2019 (COVID-19) has become a worldwide public
health crisis. At present, there are no effective antiviral drugs to treat COVID-19. Although …